DataSheet1_Optimal capacity configuration of the wind-storage combined frequency regulation system considering secondary frequency drop.docx حسب Dongdong Li (123985)

Schematic representation of semi-automated algorithm for organoids analyzing. حسب Anna Demchenko (18449439)

Time to onset of Lifitegrast-related AEs. حسب Chu Zhang (626017)

Anonymized data. حسب Michael Bonert (3751348)

"…The 538 cases were from 511 patients and 234/511 patients had lung primaries. Small cell lung cancer lesions were most frequently found in the cerebellum (17/30). …"

Biomarkers and neuroanatomical sites. حسب Michael Bonert (3751348)

"…The 538 cases were from 511 patients and 234/511 patients had lung primaries. Small cell lung cancer lesions were most frequently found in the cerebellum (17/30). …"

All tables and figures. حسب Michael Bonert (3751348)

"…The 538 cases were from 511 patients and 234/511 patients had lung primaries. Small cell lung cancer lesions were most frequently found in the cerebellum (17/30). …"

Biomarkers and cancer subtype. حسب Michael Bonert (3751348)

"…The 538 cases were from 511 patients and 234/511 patients had lung primaries. Small cell lung cancer lesions were most frequently found in the cerebellum (17/30). …"

Selected lung biomarkers. حسب Michael Bonert (3751348)

"…The 538 cases were from 511 patients and 234/511 patients had lung primaries. Small cell lung cancer lesions were most frequently found in the cerebellum (17/30). …"

Data_Sheet_1_Determination of phage load and administration time in simulated occurrences of antibacterial treatments.docx حسب Steffen Plunder (14022498)

S1 File - حسب Michael Bonert (3751348)

S2 File - حسب Michael Bonert (3751348)

Clinical history. حسب Michael Bonert (3751348)

Neuroanatomical site overlap. حسب Michael Bonert (3751348)

Overview of study assessments of the trial. حسب Tan Boon Toh (1348143)

Image 4_Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis.pdf حسب Liping Tang (77094)

"…</p>Methods<p>We integrated single-cell RNA sequencing (scRNA-seq) data from primary tumors and metastatic lesions with bulk tissue transcriptomes and plasma-derived exosomal RNA sequencing (RNA-seq). …"

Image 1_Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis.tif حسب Liping Tang (77094)

"…</p>Methods<p>We integrated single-cell RNA sequencing (scRNA-seq) data from primary tumors and metastatic lesions with bulk tissue transcriptomes and plasma-derived exosomal RNA sequencing (RNA-seq). …"

Image 7_Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis.tif حسب Liping Tang (77094)

"…</p>Methods<p>We integrated single-cell RNA sequencing (scRNA-seq) data from primary tumors and metastatic lesions with bulk tissue transcriptomes and plasma-derived exosomal RNA sequencing (RNA-seq). …"

Image 2_Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis.pdf حسب Liping Tang (77094)

"…</p>Methods<p>We integrated single-cell RNA sequencing (scRNA-seq) data from primary tumors and metastatic lesions with bulk tissue transcriptomes and plasma-derived exosomal RNA sequencing (RNA-seq). …"

Image 3_Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis.pdf حسب Liping Tang (77094)

"…</p>Methods<p>We integrated single-cell RNA sequencing (scRNA-seq) data from primary tumors and metastatic lesions with bulk tissue transcriptomes and plasma-derived exosomal RNA sequencing (RNA-seq). …"

Image 5_Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis.pdf حسب Liping Tang (77094)

"…</p>Methods<p>We integrated single-cell RNA sequencing (scRNA-seq) data from primary tumors and metastatic lesions with bulk tissue transcriptomes and plasma-derived exosomal RNA sequencing (RNA-seq). …"